En DE FR ES PL
Why Adelphan and other costs of state regulation on the drug market disappeared

Why Adelphan and other costs of state regulation on the drug market disappeared

The most popular question recently in the Directory is where did the Adelphane and other cheap medicines? A large number of our citizens are waiting for him in Moscow, St. Petersburg and other cities and villages of our country, who were helped by these cheap pills. Despite the fact that many doctors recognize these drugs as means with unproved efficacy or even harmful to health, but if a person is suitable for this medicine, then what right do we have to deprive him of the opportunity to be treated cheaply? Moreover, no one provides direct evidence of direct harm, which in the end can be considered as advertising of more expensive analogues and undeserved blackening of cheap medicines. There are speculative conclusions of experts on salary in pharmaceutical giants, which produce drugs from these diseases, but for a high price.

 

It turns out that consumers, Adel'fan and other cheap, so-called "Soviet" drugs, can not wait at all.It is economically unprofitable for producers of these medicines to produce drugs from the list of vital and essential drugs (VED) in the lowest price segment, costing up to 50 rubles, where the Adelphan considered. Firms are unprofitable to produce, pharmacies are unprofitable to sell, and state regulation of prices for drugs from this list does not allow raising prices, so it is easier to abandon production, although it is thought that even with a rise of tens of percent, the prices for these drugs will still remain competitive compared to imports or expensive domestic counterparts. We only need to adequately look at the market, including government officials, and do not pinch the nuts, otherwise soon there will be nothing left in the segment of cheap drugs, although formally these drugs will be present on preferential lists, and by availability in pharmacies - no.

 

Do not relax consumers and other cheap medicines because according to the Federal Antimonopoly Service (FAS), almost 200 cheap drugs have already been discontinued, about one and a half hundred companies plan to stop issuing them in the near future.That is, it will only get worse and many could already notice the boredom of the assortment in the lowest price range of pharmacies. And what should people do in regions where there is sometimes a question to buy a piece of bread or a medicine? Not everyone has the opportunity to receive Moscow salaries, although many Muscovites would also not mind continuing to be treated with time-tested drugs, especially retirees.

 

If officials see that drugs disappear from the market - it is necessary to release economic reins, let the sellers raise prices. The manufacturer knows its consumer and pawns a price that would benefit both the consumer and the company, no one will produce an expensive drug so that it will not be sold. Now we have a pedaling problem by all that will lead to the disappearance of this group of drugs, and to establish the production of cheap medicines later (in case of adequate regulation), no one will be, since the lines will be occupied with the production of more marginal drugs.

 

Of course, no one thinks about consumers, as a result, even quacks to these drugs are attempted by charlatans who offer these drugs, imported allegedly from India or Europe, at wild prices, but cheaper than their counterparts.I block this kind of advertising and consider it immoral and harmful, but many will be poisoned with medicinal counterfeit, which has no certificates, or the correct formula, can even be a pacifier or a fake created for profit, because it's easy to deceive older people. And how many will lose the health, nerves and money of patients who will be transferred to other drugs, while adequate therapy schemes are selected. This is a wild stress for the elderly. Nobody thinks about people again ...

Reviews (0):

Rules for publishing reviews and visitor questions